Structure Therapeutics Inc (GPCR) Stock Price, Chart, News and AI analysis

Q: Who is the CEO of Structure Therapeutics Inc?

Dr. Raymond Stevens is the Chief Executive Officer of Structure Therapeutics Inc, joining the firm since 2019.

Q: What is the price performance of GPCR stock?

The current price of GPCR is $69.55, it has increased 0.01% in the last trading day.

Q: What are the primary business themes or industries for Structure Therapeutics Inc?

Structure Therapeutics Inc belongs to Pharmaceuticals industry and the sector is Health Care

Q: What is Structure Therapeutics Inc market cap?

Structure Therapeutics Inc's current market cap is $4.2B

Q: Is Structure Therapeutics Inc a buy, sell, or hold?

According to wall street analysts, 15 analysts have made analyst ratings for Structure Therapeutics Inc, including 8 strong buy, 11 buy, 1 hold, 0 sell, and 8 strong sell

Home

Stock

GPCR

GPCR Price

Structure Therapeutics Inc

$69.54

2.58%

$1.75

At close: Dec 30, 16:00:00 GMT-5

$69.55

0.01%

$0

Post-market: Dec 30, 20:00:00 GMT-5

Overview Forecast Earnings Dividends Financials



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Resources

Market

Ask AI About GPCR

Ask a question to get started...

No Data Yet

Supported by

+3.22%

+9.96%

30D

+88.89%

+337.42%

YTD

+155.51%

+3.22%

+9.96%

30D

+88.89%

+337.42%

YTD

+155.51%

Follow-Up Questions

Who is the CEO of Structure Therapeutics Inc?



What is the price performance of GPCR stock?



What are the primary business themes or industries for Structure Therapeutics Inc?



What is Structure Therapeutics Inc market cap?



Is Structure Therapeutics Inc a buy, sell, or hold?



Follow-Up Questions

Who is the CEO of Structure Therapeutics Inc?



What is the price performance of GPCR stock?



What are the primary business themes or industries for Structure Therapeutics Inc?



What is Structure Therapeutics Inc market cap?



Is Structure Therapeutics Inc a buy, sell, or hold?



Structure Therapeutics Inc (GPCR) Price

GPCR Stock Price Chart

Related News

Structure Therapeutics Stock Climbs 3.92% on New Obesity Drug Trial

Structure Therapeutics Raises $747.5M in Upsized Offering

Biotechs Challenge Lilly's Obesity Drug Dominance

Zealand Pharma Intensifies Weight-Loss Drug Race

GLP-1 Drug Demand Fuels Supplier Growth

Competition Batters Novo Nordisk Market Dominance

New Obesity Drug Data Challenges Market Leaders

Follow-Up Questions

Who is the CEO of Structure Therapeutics Inc?

What is the price performance of GPCR stock?

What are the primary business themes or industries for Structure Therapeutics Inc?

What is Structure Therapeutics Inc market cap?

Is Structure Therapeutics Inc a buy, sell, or hold?

Related News

Structure Therapeutics Stock Climbs 3.92% on New Obesity Drug Trial

Structure Therapeutics Raises $747.5M in Upsized Offering

Biotechs Challenge Lilly's Obesity Drug Dominance

Zealand Pharma Intensifies Weight-Loss Drug Race

GLP-1 Drug Demand Fuels Supplier Growth

Competition Batters Novo Nordisk Market Dominance

New Obesity Drug Data Challenges Market Leaders

Follow-Up Questions

Who is the CEO of Structure Therapeutics Inc?

What is the price performance of GPCR stock?

What are the primary business themes or industries for Structure Therapeutics Inc?

What is Structure Therapeutics Inc market cap?

Is Structure Therapeutics Inc a buy, sell, or hold?